Study on the Accuracy of Determining the Responsible Vessel in Medium Vessel Occlusive Stroke Based on Multi-type CT Evaluation
1 other identifier
observational
622
1 country
1
Brief Summary
To evaluate the accuracy of diagnosing the qualifying artery in patients with medium vessel occlusion stroke based on multimodal CT
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 13, 2025
CompletedFirst Submitted
Initial submission to the registry
January 9, 2026
CompletedFirst Posted
Study publicly available on registry
January 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 13, 2026
CompletedJanuary 16, 2026
January 1, 2026
1 year
January 9, 2026
January 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The difference in accuracy between the evaluation of MeVO stroke using multimode CT and that using NCCT+CTA
The difference in accuracy between the evaluation of MeVO stroke using multimode CT and that using NCCT+CTA
at baseline
Secondary Outcomes (2)
The time required by the reader to identify the qualifying artery before and after using CTP
at baseline
The consistency between the core infarction volume evaluated based on CTP and the final infarction volume obtained from MRI examination within 7 days after the onset
7 days after the onset
Study Arms (2)
NCCT+CTA group
The attending physicians of neurology (with more than 5 years of experience in neuroimaging interpretation and not relevant to this study), without knowing the final radiological report, DSA, MRI results and clinical manifestations, only used baseline non-contrast CT (NCCT) and CTA to determine whether the included cases had moderate vascular occlusion. And record the qualifying artery
NCCT+CTA+CTP group
The attending physicians of neurology (with more than 5 years of experience in neuroimaging interpretation and not relevant to this study), without knowing the final radiological report, DSA, MRI results and clinical manifestations, only used baseline non-contrast CT (NCCT) , CTA and CTP to determine whether the included cases had moderate vascular occlusion. And record the qualifying artery
Eligibility Criteria
According to previous literature reports, the prevalence of MeVO stroke accounts for 18% of ischemic stroke. It is estimated that the sensitivity of NCCT + CTA in diagnosing MeVO is 74%. Based on multimodal CT, the sensitivity for diagnosing moderate vascular occlusive stroke can be increased by 15%, reaching 89%. The test level is bilateral 0.05, and the confidence level 1 - β = 0.8. Then, at least 622 research subjects are required. Among them, the number of patients with MeVO, N1 = 622 \* 0.18 = 112 cases.
You may qualify if:
- Patients with acute ischemic stroke, without restrictions on gender
- Age ≥ 18 years old
- The time from onset to treatment is within 24 hours (the onset time is defined as the "last-well-time", and the treatment plan is determined according to the patient's wishes and local clinical experience)
- Before the treatment, CT, CTA and CTP examinations were conducted, and the relevant clinical data were complete.
You may not qualify if:
- Patients with acute intracranial hemorrhage
- Patients whose CTP original images cannot be processed by the CTP post-processing software
- Patients for whom the DICOM format image data of CT, CTP original images and MRI images cannot be obtained, or whose image quality is poor due to various reasons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xuanwu Hospital, Beijinglead
- Beijing Hospitals Authoritycollaborator
Study Sites (1)
Xuanwu Hospital Capital Medical University
Beijing, Beijing Municipality, 100053, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2026
First Posted
January 16, 2026
Study Start
March 13, 2025
Primary Completion
March 13, 2026
Study Completion
March 13, 2026
Last Updated
January 16, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share